Harrow Health Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -153.2% | – | – | -702.5% | – | -104.1% | – | -49.3% | -206.9% | – | – | |
| – | -3.2% | +3.6% | +0.6% | +4.6% | +43.8% | +2.0% | -0.1% | -0.1% | +1.4% | +12.4% | -200.0% | – | |
| – | -6.7% | -0.1% | +2.4% | +2.7% | +9.3% | -5.0% | -80.8% | +273.8% | +16.2% | +1.0% | -200.0% | – | |
| – | – | -106.3% | – | – | – | – | -149.2% | – | – | – | -200.0% | – | |
| – | -99.0% | -54.7% | +273.9% | +75.6% | +6,118.5% | -99.4% | -21.7% | +35.5% | +51.6% | -43.1% | +0.0% | – | |
| – | -99.0% | -45.8% | – | -111.7% | +6,191.5% | -99.4% | +38.2% | -23.2% | +2,002.2% | +284.8% | -97.1% | – | |
| – | -99.7% | +2,654.8% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -100.0% | – | – | -100.0% | – | -100.0% | – | |
| – | -100.0% | +4,394.4% | – | -1,087.7% | – | -99.9% | -55,173.9% | – | -201.6% | – | -101.0% | – | |
| – | -80.2% | -165.5% | – | -32.8% | -1,652.6% | – | -170.7% | – | -106.4% | – | -149.6% | – | |
| – | – | -155.6% | – | – | -2,457.9% | – | -105.0% | – | -50.7% | -213.8% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.